Corcept (CORT) Form 144: 20,000-Share Option Sale

Corcept Therapeutics Inc. reported proposed sales of common stock by an affiliate under a Form 144 notice.

Rhea-AI Filing Summary

Corcept Therapeutics Inc. reported proposed sales of common stock by an affiliate under a Form 144 notice. The filing lists a 20,000-share sale associated with a stock option exercise on 06/02/2026 and several prior dispositions in March–May 2026.

The filings show prior reported sales of 20,000 shares on 04/08/2026 for $819,453.00, 8,233 shares on 03/04/2026 for $296,346.00, 11,767 shares on 03/20/2026 for $423,707.00, and 20,000 shares on 05/06/2026 for $1,036,522.00. The broker listed is Stifel Nicolaus & Company Inc.

Insights

Securities Compliance Attorney

Form 144 notice documents proposed resale of registered shares by an affiliate.

The filing lists proposed sales tied to a stock option exercise and multiple prior dispositions with broker identification. Form 144 is a notice used to satisfy resale reporting requirements under the securities laws.

Timing and cash‑flow treatment are shown as Cash for the 06/02/2026 entry; subsequent public filings will show whether the sales occurred and their exact mechanics.

Key Figures

06/02/2026 transaction: 20,000 shares Proceeds shown (06/02/2026): $1,408,800.00 04/08/2026 disposition: 20,000 shares +7 more

10 metrics

06/02/2026 transaction 20,000 shares Stock Option Exercise on <date>06/02/2026</date>

Proceeds shown (06/02/2026) $1,408,800.00 Amount listed alongside the 20,000-share 06/02/2026 entry

04/08/2026 disposition 20,000 shares Reported sale on <date>04/08/2026</date>

Proceeds shown (04/08/2026) $819,453.00 Amount listed for the 04/08/2026 sale

03/04/2026 disposition 8,233 shares Reported sale on <date>03/04/2026</date>

Proceeds shown (03/04/2026) $296,346.00 Amount listed for the 03/04/2026 sale

03/20/2026 disposition 11,767 shares Reported sale on <date>03/20/2026</date>

Proceeds shown (03/20/2026) $423,707.00 Amount listed for the 03/20/2026 sale

05/06/2026 disposition 20,000 shares Reported sale on <date>05/06/2026</date>

Proceeds shown (05/06/2026) $1,036,522.00 Amount listed for the 05/06/2026 sale

Key Terms

Form 144, Stock Option Exercise, Cash

3 terms

Form 144 regulatory

"lists proposed resale transactions and broker for affiliate sales"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"identified as the transaction type for the 06/02/2026 entry"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Cash financial

"payment/settlement method listed for the 06/02/2026 transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Corcept (CORT) Form 144 filing disclose?

The filing discloses proposed resale transactions including a 20,000-share stock option exercise on 06/02/2026. It also lists prior reported sales in March–May 2026 with specific share counts and proceeds.

Who is the broker handling the sale in the CORT Form 144?

The broker listed is Stifel Nicolaus & Company Inc.. The filing identifies the broker's address and associates the 20,000-share 06/02/2026 transaction with that broker.

How many shares and proceeds are shown for the 06/02/2026 transaction?

The 06/02/2026 entry shows 20,000 shares with an associated amount of $1,408,800.00. The transaction type is described as a Stock Option Exercise settled in Cash.

Who reported the prior share dispositions listed in the filing?

The prior dispositions are reported under the name William Guyer, showing sales of 20,000, 8,233, 11,767, and 20,000 shares on specific dates with corresponding proceeds.

Does the Form 144 confirm the shares were sold on the open market?

The filing lists proposed sales by an affiliate and identifies sale dates and amounts; it is a notice of intended resale and does not by itself confirm execution on the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 02:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001879013
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CORCEPT THERAPEUTICS INC
SEC File Number	000-50679
Address of Issuer	101 REDWOOD SHORES PARKWAY REDWOOD CITY CALIFORNIA 94065
Phone	650.688.8803
Name of Person for Whose Account the Securities are To Be Sold	Guyer William
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Stifel Nicolaus & Company Inc. 501 N. Broadway St. Louis MO 63102	20000	1408800.00	107350000	06/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/02/2026	Stock Option Exercise	Corcept Therapeutics Inc.			20000	06/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
William Guyer 101 Redwood Shores Parkway Redwood City CA 94065	Common	04/08/2026	20000	819453.00
William Guyer 101 Redwood Shores Parkway Redwood City CA 94065	Common	03/04/2026	8233	296346.00
William Guyer 101 Redwood Shores Parkway Redwood City CA 94065	Common	03/20/2026	11767	423707.00
William Guyer 101 Redwood Shores Parkway Redwood City CA 94065	Common	05/06/2026	20000	1036522.00

144: Remarks and Signature

Remarks
Date of Notice	06/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/27/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Toni Dobel, as a duly authorized representative of STIFEL, as attorney-in-fact for William Guyer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)